M.S. Ramazanova1,2, A.S. Chernyatyeva1, A.S. Kopanev1, A.A. Kuzmin1
1Kirov Regional Clinical Oncologic Center, Kirov
2Kirov State Medical University, Kirov
Ramazanova M.S. ― chemotherapist of day hospital of the Kirov Regional Clinical Oncology Center, docent at the Oncology Department of the Kirov State Medical University
23 Stroiteley Ave., Kirov, Russian Federation, 610021, tel. +7-912-702-24-85, e-mail: ramazanovam@inbox.ru
Abstract
Introduction. This article presents an analysis of the incidence rate of head and neck organs in the Kirov Region and Russia, highlights the possibilities of using the targeted drug cetuximab for metastatic squamous cell carcinoma of these sites in clinical practice.
The aim of the work was to study the statistical data of head and neck cancer in the Kirov region, as well as to show modern approaches to the treatment of cancer of these localizations using a clinical example.
Material and methods. The basis of the study was the Kirov Regional Clinical Oncological Center, which carries out registration, registration and clinical examination of patients with malignant tumors. It is based on data on patients with Head and neck cancer of the Kirov region and Russia as a whole for 2013-2017.
Conclusion. Head and neck Cancer is an actual problem in the Kirov region and in Russia. Cetuximab therapy for recurrent cancer of the head and neck organs is quite effective, significantly alleviating the symptoms of the disease and preserving the patient’s quality of life. And it can be used in patients with different functional
Key words: malignant tumors of the head and neck organs, morbidity, neglect, one-year mortality, squamous cell carcinoma of the maxillary sinus, cetuximab.